medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2015, Number 08

<< Back Next >>

Ginecol Obstet Mex 2015; 83 (08)

First trimester uric acid and adverse pregnancy outcomes in patients with chronic glomerulonephritis during pregnancy

Sequeira-Alvarado KA, Hernández-Pacheco JA, Espino SS

Language: Spanish
References: 11
Page: 461-466
PDF size: 450.69 Kb.


ABSTRACT

Background: The association between hyperuricemia and adverse perinatal outcome has been studied on numerous occasions, particularly in relation to hypertension and preeclampsia.
Objectives: The objective of this study is to analyze the predictive value of serum concentrations of uric acid during the first trimester of pregnancy for adverse perinatal outcome in women with glomerulopathies.
Material and methods: Twenty-five women diagnosed with glomerulonephritis at the Instituto Nacional de Perinatología were included in this study. The determination of serum uric acid concentration was made between 7 and 12 weeks of gestation.
Results: We finding that Uric acid level in the first trimester showed a significant correlation with blood pressure in the third trimester (Spearman rho coefficient: 0.45, p=0.04,), with weeks of gestation at birth (Spearman rho coefficient: -0.42, p 0.05), and with weight at birth (Spearman rho coefficient: -0.61 p=0.003).
Conclusions: The findings of our study suggest the clinical utility of determining and interpreting uric acid in the first trimester in patients with glomerulopathias and mild renal insufficiency (creatinine less than 1.4 mg/dL), and a threshold of 4.8 mg/dL to consider at which a patient can be considered at high risk of premature birth, low birth weight, and preeclampsia.


REFERENCES

  1. Piccoli GB, Cabiddu G, Attini R, Vigotti F, Fassio F, Rolfo A, Giuffrida D, Pani A, Gaglioti P, Todros T. Pregnancy in CKD: Questions and answers in a changing panorama. 2015. [En línea]. Dirección URL: .

  2. Smyth A, Radovic M, Garovic VD. Women, kidney disease, and pregnancy. Adv Chronic Kidney Dis 2013;20:402-410.

  3. Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in pre-eclampsia. Placenta 2008;22(Suppl A):S67-S72.

  4. Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, Powers RW. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 2005;46:1263-1269

  5. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced Creactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005;16:3553-35562.

  6. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Troug L, Harris R, Johnson RJ. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002;13:2888-2897.

  7. Maples KR, Mason RP. Free radical metabolite of uric acid. J Biol Chem 1988;263:1709-1712.

  8. Brainbridge SA, Versen-Höynck F, Roberts JM. Uric acid inhibits placental system a amino acid uptake. Placenta 2009;30:195-200.

  9. Powers RW, Bodnar LM, Ness RB, Cooper KM, Gallaher MJ, Frank MP, Daftary AR, Roberts JM.Uric acid concentrations in early pregnancy among pre-eclamptic women with gestational hyperuricemia at delivery. Am J Obstet Gynecol 2006;194:160

  10. Amini E, Sheikh M, Hantoushzadeh S, Shariat M, Abdollahi A, Kashanian M. Maternal hyperuricemia in normotensive singleton pregnancy, a prenatal finding with continuous perinatal and postnatal effects, a prospective cohort study. BMC Pregnancy Childbirth 2014;14:104.

  11. Laughon SK, Catov J, Powers RW, Roberts JM, Gandley RE. First trimester uric and adverse pregnancy outcomes. Am J Hypertens 2011;24:489-495.




2020     |     www.medigraphic.com